Propranolol eye micro-drops, while well tolerated, may have limited efficacy in preterm infants with stage 2 retinopathy of prematurity (ROP), according to the results of a pilot trial.
Insulin degludec and Gla-300 appear to provide effective glycaemic control with a good safety profile in types 1 and 2 diabetes mellitus (T1DM and T2DM), according to a literature review. This benefit may be attributed to the improved insulin delivery of >24 hours.
Infliximab exposure does not appear to contribute to an increased risk of malignancy or hemophagocytic lymphohistiocytosis (HLH) in paediatric patients with inflammatory bowel disease (IBD), whereas thiopurine exposure is an important precedent for developing malignancy or HLH in this population, according to a study.
There have been significant changes in the treatment patterns among patients with psoriatic arthritis (PsA) from 2004 to 2012, according to a recent study.
Concomitant use of proton pump inhibitors (PPIs) and medications from several drug classes may pose an increased risk of adverse events, according to a review of patient-centred outcomes.
Maternal infection following caesarean delivery appears to persist as a significant source of morbidity despite use of prophylactic azithromycin-based extended-spectrum antibiotic preincision, according to a study.
Dexamethasone appears to have the strongest association with the development of hiccups among other drugs examined in the Japanese Adverse Drug Event Report, a new study reveals. Moreover, not only are hiccups a side effect of medication, but the onset of these events may be influenced by patient backgrounds.
Use of dexamethasone 8 mg prior to surgical incision may benefit adults undergoing laparoscopic cholecystectomies and thyroid surgery, as well as children having tonsillectomies, according to the results of a critical review.
Treatment with ibandronate may effectively reduce bone mineral density (BMD) loss in women with rheumatoid arthritis (RA) who are receiving long-term glucocorticoids, according to a study.
Treatment with enteric-coated (EC) aspirin does not completely inhibit serum thromboxane B2 (TXB2) generation in a high proportion of patients with diabetes due to incomplete absorption, according to a new study.